Table 1.
Total | 36 |
---|---|
Demographics | |
Age (median [IQR], Range) | 49 [43.5, 55.25] (24–62) |
Sex (Male/Female) | 8/28 |
SARS-CoV-2 Prior Infection (Yes/No) | 11/28 |
BNT162b2 Samples (1st dose/2nd Dose) | 13/13 |
mRNA-1273 Samples (1st dose/2nd Dose) | 7/7 |
AZD1222 Samples (1st dose/2nd Dose) | 16/16 |
Time of bleed after 1st dose | 21 days (BNT162b2 and mRNA-1273) 12 weeks (AZD1222) |
Time of bleed after 2nd dose | 15 weeks |